Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/37145994

Research summary

This study investigates the role of 4E-BP1 serine 82 phosphorylation in regulating cell proliferation and tumor suppression. Mice with a serine-to-alanine substitution at position 82 (S82A) in 4E-BP1 exhibit increased susceptibility to polycystic kidney and liver disease, as well as T-cell lymphomas upon sublethal irradiation, indicating the importance of this phosphorylation site in maintaining tissue homeostasis.

Key outcome of the study

Loss of 4E-BP1 serine 82 phosphorylation leads to proliferative polycystic disease and increased lymphoma incidence in aged or irradiated mice, highlighting the critical role of this modification in controlling cell proliferation and preventing tumorigenesis.

Mouse model

4E-BP1 (S82A) Knockin mouse model developed by genOway, featuring a serine-to-alanine substitution at position 82 to prevent phosphorylation at this site. The model was generated via homologous recombination in embryonic stem cells, followed by Cre-mediated excision of a selection cassette.

TARGET:
Eif4ebp1
4E-BP1, Eukaryotic translation initiation factor 4E-binding protein 1

Keywords

Cancer biology, Cell cycle regulation, Phosphorylation, Tumor suppression, Translational control

Technical specifications

Point mutation Knockin model, Homologous recombination, Cre-loxP system, Phosphorylation site mutation, Functional protein analysis

Related products

Catalogue product

No items found.

Customized product

Point mutation KI mouse

Use a point mutation mouse Knockin to circumvent complex phenotypes arising from complete Knockouts (e.g., signaling pathway problems, cross-reactivity).